Trastuzumab-associated cardiac events at 8 years of median follow-up in the Herceptin Adjuvant trial (BIG 1-01).

MLA

de Azambuja, Evandro, et al. “Trastuzumab-Associated Cardiac Events at 8 Years of Median Follow-up in the Herceptin Adjuvant Trial (BIG 1-01).” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 32, no. 20, July 2014, pp. 2159–65. EBSCOhost, https://doi.org/10.1200/JCO.2013.53.9288.

APA

de Azambuja, E., Procter, M. J., van Veldhuisen, D. J., Agbor-Tarh, D., Metzger-Filho, O., Steinseifer, J., Untch, M., Smith, I. E., Gianni, L., Baselga, J., Jackisch, C., Cameron, D. A., Bell, R., Leyland-Jones, B., Dowsett, M., Gelber, R. D., Piccart-Gebhart, M. J., & Suter, T. M. (2014). Trastuzumab-associated cardiac events at 8 years of median follow-up in the Herceptin Adjuvant trial (BIG 1-01). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 32(20), 2159–2165. https://doi.org/10.1200/JCO.2013.53.9288

Chicago

de Azambuja, Evandro, Marion J Procter, Dirk J van Veldhuisen, Dominique Agbor-Tarh, Otto Metzger-Filho, Jutta Steinseifer, Michael Untch, et al. 2014. “Trastuzumab-Associated Cardiac Events at 8 Years of Median Follow-up in the Herceptin Adjuvant Trial (BIG 1-01).” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 32 (20): 2159–65. doi:10.1200/JCO.2013.53.9288.